CM
VIR icon

Caption Management’s Vir Biotechnology VIR Stock Holding History

Caption Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,000
Closed -$228K – 2087
2025
Q3 		$228K Hold
40,000
– – ﹤0.01% 1447
2025
Q2 		$202K Hold
40,000
– – ﹤0.01% 1258
2025
Q1 		$259K Sell
40,000
-27,500
-41% -$245K ﹤0.01% 1226
2024
Q4 		$495K Buy
67,500
+49,500
+275% +$390K ﹤0.01% 1107
2024
Q3 		$135K Buy
+18,000
New +$156K ﹤0.01% 1103
2024
Q2 		– Sell
-22,500
Closed -$228K – 1534
2024
Q1 		$228K Sell
22,500
-75,000
-77% -$764K ﹤0.01% 991
2023
Q4 		$981K Buy
+97,500
New +$891K 0.01% 810
2023
Q2 		– Sell
-34,600
Closed -$805K – 1426
2023
Q1 		$805K Buy
+34,600
New +$885K 0.02% 677
2022
Q4 		– Sell
-60,000
Closed -$1.16M – 1751
2022
Q3 		$1.16M Buy
60,000
+30,000
+100% +$763K 0.02% 818
2022
Q2 		$764K Buy
+30,000
New +$700K 0.01% 962
2022
Q1 		– Sell
-13,200
Closed -$551K – 1978
2021
Q4 		$551K Sell
13,200
-20,300
-61% -$795K 0.01% 1229
2021
Q3 		$1.46M Sell
33,500
-42,500
-56% -$1.84M 0.02% 895
2021
Q2 		$3.59M Sell
76,000
-25,000
-25% -$1.14M 0.05% 478
2021
Q1 		$5.18M Buy
+101,000
New +$5.44M 0.11% 235

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Caption Management's VIR Position: Q3 2025 in Review

Caption Management sold out of Vir Biotechnology (VIR) in Q3 2025, closing a stake of 12,600 shares — an estimated $64.4K sold.

Caption Management first reported a position in VIR in Q1 2023 and held it in 4 quarters. The position peaked at $175K in Q1 2023. 213 funds tracked by Wall St. Rank hold VIR as of Q3 2025.

  • Caption Management reported no remaining Vir Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Caption Management sold 12,600 Vir Biotechnology shares in Q3 2025, an estimated $64.4K.
  • Caption Management first reported a position in Vir Biotechnology in Q1 2023 and held it in 4 quarters.
  • Caption Management's Vir Biotechnology position peaked at $175K in Q1 2023.
  • 213 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.